Business
Gelteq to Present at Investor Summit Virtual on December 9, 2025
MELBOURNE, Australia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (Nasdaq: GELS) (“Gelteq”) today announced that Nathan Givoni, its Chief Executive Officer, will present at the Q4 Investor Summit Virtual on December 9, 2025, where he will share updates on Gelteq’s growth strategy, market positioning, and upcoming catalysts. The Investor Summit is an exclusive virtual event connecting investors with disruptive small and microcap companies. This quarter’s event highlights MicroCap companies w
About this update from Gelteq Limited
[{"type":"image","alt":"Gelteq Limited","displaySize":"","headline":null,"caption":"Gelteq Limited","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":45,"url":"https://media.zenfs.com/en/globenewswire.com/7b1e561b8eb101a1e67d96e6f6066b43"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/uXs2phR.sCaPuzjk7r6BAw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTYzO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/7b1e561b8eb101a1e67d96e6f6066b43","width":300,"height":45}},"lazy":false},{"type":"text","content":"MELBOURNE, Australia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (Nasdaq: GELS) (“Gelteq”) today announced that Nathan Givoni, its Chief Executive Officer, will present at the Q4 Investor Summit Virtual on December 9, 2025, where he will share updates on Gelteq’s growth strategy, market positioning, and upcoming catalysts. The Investor Summit is an exclusive virtual event connecting investors with disruptive small and microcap companies. This quarter’s event highlights MicroCap companies with compelling value propositions and near-term growth drivers, offering investors a focused platform for discovery.","length":621,"tagName":"p"},{"type":"text","content":"Mr. Givoni will be presenting on December 9 at 4:00 PM ET, together with hosting one-on-one meetings with Institutional and High Net Worth (HNW) investors on December 10th. To request a one-on-one meeting, please reach out to the conference contact or Gelteq investor relations, [email protected].","length":299,"tagName":"p"},{"type":"text","content":"Event Details:","length":14,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Event: Q4 Investor Summit","length":25,"tagName":"p"}]},{"val":[{"type":"text","content":"Presentation Date & Time: December 9 | 4:00 PM ET","length":53,"tagName":"p"}]},{"val":[{"type":"text","content":"Request Access: https://investorsummitgroup.com/","length":48,"tagName":"p"}]},{"val":[{"type":"text","content":"Conference Contact: For more information, please contact: [email protected]","length":86,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":212,"olType":false},{"type":"text","content":"About Gelteq Ltd.Headquartered in Melbourne, Australia, Gelteq (NASDAQ: GELS) is a clinical and science-based company dedicated to developing and commercialising gel-based oral delivery solu...